US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Sarepta Therapeutics

21.03

+0.17000.81%

Post-market: 20.84-0.1900-0.90%19:49 EDT

Volume:2.66M

Turnover:55.56M

Market Cap:2.22B

PE:-15.98

High:21.16

Open:20.56

Low:20.18

Close:20.86

52wk High:25.32

52wk Low:14.68

Shares:105.57M

Float Shares:99.05M

Volume Ratio:0.78

T/O Rate:2.68%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.3161

EPS(LYR):-7.1300

ROE:-9.48%

ROA:-1.13%

PB:1.45

PE(LYR):-2.95

Loading ...

Overview Company News Filings

Sarepta Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS

Sarepta Shares up on FDA Acceptance of Supplemental New Drug Applications

Sarepta Therapeutics Gets FDA Review for Duchenne Muscular Dystrophy Applications

MT Newswires Live

Sarepta Says FDA Accepts Amondys 45, Vyondys 53 Sndas for Review, Sets Feb. 28, 2027 PDUFA Date

Sarepta Therapeutics - FDA Sets Pdufa Target Action Date of February 28, 2027

THOMSON REUTERS

Sarepta Announces FDA Acceptance of Sndas for Amondys 45® and Vyondys 53®

THOMSON REUTERS

Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT), Eli Lilly & Co (LLY) and C4 Therapeutics (CCCC)

Barclays Sticks to Its Hold Rating for Sarepta Therapeutics (SRPT)

Sarepta Therapeutics (SRPT) Stock Could Be 19% Undervalued As Elevidys Outlook Steadies

Simply Wall St.

Sarepta's Elevidys Showing Signs of Stabilization as siRNA Pipeline Gains Importance, RBC Says

MT Newswires Live

Is Sarepta Therapeutics (SRPT) Quietly Rewriting Its Risk Profile With New Equity Plans And Q1 Profitability?

Simply Wall St.

A Look At Sarepta Therapeutics (SRPT) Valuation After New Shelf Registration For Potential Share Offering

Simply Wall St.

Sarepta Therapeutics shareholders approve 2026 equity incentive plan at annual meeting

SRPT Expands Into Huntington’s Disease With New First-in-Human Trial

Acting US FDA chief meets with rare disease groups to mend fences

Sarepta Therapeutics to present at Goldman Sachs Global Healthcare Conference

A Look At Sarepta Therapeutics (SRPT) Valuation After Recent Share Price Weakness And ELEVIDYS Safety Concerns

Simply Wall St.

J.P. Morgan Remains a Hold on Sarepta Therapeutics (SRPT)

Sarepta's Elevidys Faces 'Little' Pressure After Regenxbio Data, Wedbush Says

MT Newswires Live

Sarepta Therapeutics: Buy Rating Reiterated on Elevidys Uptake Outlook and Microdystrophin Validation; $35 Price Target Unchanged

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/SRPT/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SRPT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SRPT\",,,,,undefined,":{"symbol":"SRPT","market":"US","secType":"STK","nameCN":"Sarepta Therapeutics","latestPrice":21.03,"timestamp":1788206400000,"preClose":20.86,"halted":0,"volume":2656894,"hourTrading":{"tag":"盘后","latestPrice":20.84,"preClose":21.03,"latestTime":"19:49 EDT","volume":131324,"amount":2761692.860324,"timestamp":1788220164212,"change":-0.19,"changeRate":-0.009035,"amplitude":0.009035},"delay":0,"changeRate":0.008149568552253197,"floatShares":99052564,"shares":105571146,"eps":-1.316144,"marketStatus":"Not Yet Opened","change":0.17,"latestTime":"08-31 16:00:00 EDT","open":20.56,"high":21.16,"low":20.1821,"amount":55562959.9985,"amplitude":0.046879,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.316144,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788249600000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":865396800000,"exchange":"NASDAQ","adjPreClose":20.86,"preHourTrading":{"tag":"盘前","latestPrice":20.55,"preClose":20.86,"latestTime":"09:29 EDT","volume":2123,"amount":44083.959127999995,"timestamp":1788182999999,"change":-0.31,"changeRate":-0.014861,"amplitude":0.019175},"postHourTrading":{"tag":"盘后","latestPrice":20.84,"preClose":21.03,"latestTime":"19:49 EDT","volume":131324,"amount":2761692.860324,"timestamp":1788220164212,"change":-0.19,"changeRate":-0.009035,"amplitude":0.009035},"volumeRatio":0.78047,"impliedVol":0.7004,"impliedVolPercentile":0.2032},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SRPT\",,,,,undefined,":{"symbol":"SRPT","floatShares":99052564,"roa":"-1.13%","roe":"-9.48%","lyrEps":-7.13,"volumeRatio":0.78047,"shares":105571146,"dividePrice":0,"high":21.16,"amplitude":0.046879,"preClose":20.86,"low":20.1821,"week52Low":14.68,"pbRate":"1.45","psRate":"1.12","week52High":25.32,"institutionHeld":0.86,"latestPrice":21.03,"eps":-1.316144,"divideRate":0,"volume":2656894,"delay":0,"ttmEps":-1.316144,"open":20.56,"prevYearClose":21.52,"prevWeekClose":20.86,"prevMonthClose":14.86,"prevQuarterClose":17.97,"fiveDayClose":18.13,"twentyDayClose":15.88,"sixtyDayClose":16.66},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SRPT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-05","symbol":"SRPT","fiscalQuarterEnding":"2026/06","expectedEps":0.34,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"post","actualEps":0.42},{"market":"US","date":"2026-05-06","symbol":"SRPT","fiscalQuarterEnding":"2026/03","expectedEps":0.39,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778040000000,"reportTimeType":"post","actualEps":3.09},{"market":"US","date":"2026-02-25","symbol":"SRPT","fiscalQuarterEnding":"2025/12","expectedEps":-1.03,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1771995600000,"reportTimeType":"post","actualEps":-3.87},{"market":"US","date":"2026-01-12","symbol":"SRPT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1768194000000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2025-11-03","symbol":"SRPT","fiscalQuarterEnding":"2025/09","expectedEps":-0.37,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762146000000,"reportTimeType":"post","actualEps":-0.28}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SRPT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SRPT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2222,"buy":0.1111,"hold":0.4444,"sell":0.1852,"strongSell":0.037,"meanLabel":"HOLD","meanPercent":0.4444,"analysts":27,"updateTime":1783742400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SRPT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SRPT","date":"2026-08-28","current":-15.978495,"percent":0.234078,"low":-40.834762,"twenty":-17.312547,"median":-11.967505,"eighty":27.380328,"high":883.870215,"avg":41.454761,"sd":160.886046,"marketCap":2280487383},"quantilePoints":[{"date":"2021-09-03","current":-10.131737,"twenty":-33.487457,"median":-14.922795,"eighty":-9.888388,"marketCap":6428293093},{"date":"2021-09-10","current":-10.126703,"twenty":-33.487457,"median":-14.922795,"eighty":-9.898273,"marketCap":6425099307},{"date":"2021-09-17","current":-10.870444,"twenty":-33.487457,"median":-14.922795,"eighty":-9.947169,"marketCap":6896981212},{"date":"2021-09-24","current":-11.397732,"twenty":-33.487457,"median":-14.8974,"eighty":-9.947169,"marketCap":7231530312},{"date":"2021-10-01","current":-12.087359,"twenty":-33.487457,"median":-14.824584,"eighty":-9.947169,"marketCap":7669079016},{"date":"2021-10-08","current":-12.511455,"twenty":-33.487457,"median":-14.768842,"eighty":-9.947169,"marketCap":7938155500},{"date":"2021-10-15","current":-11.536802,"twenty":-33.487457,"median":-14.670631,"eighty":-9.947169,"marketCap":7319766529},{"date":"2021-10-22","current":-10.995522,"twenty":-33.487457,"median":-14.665323,"eighty":-9.947169,"marketCap":6976340020},{"date":"2021-10-29","current":-10.843416,"twenty":-33.487457,"median":-14.665323,"eighty":-9.947169,"marketCap":6879832824},{"date":"2021-11-05","current":-15.92984,"twenty":-33.487457,"median":-14.721064,"eighty":-9.947169,"marketCap":7743750317},{"date":"2021-11-12","current":-15.21512,"twenty":-33.487457,"median":-14.780826,"eighty":-9.947169,"marketCap":7396313414},{"date":"2021-11-19","current":-14.33202,"twenty":-33.487457,"median":-14.79804,"eighty":-9.947169,"marketCap":6967024209},{"date":"2021-11-26","current":-14.26216,"twenty":-33.487457,"median":-14.79804,"eighty":-9.947169,"marketCap":6933064211},{"date":"2021-12-03","current":-14.061537,"twenty":-33.487457,"median":-14.824584,"eighty":-9.981016,"marketCap":6835538063},{"date":"2021-12-10","current":-15.313641,"twenty":-33.487457,"median":-14.868557,"eighty":-10.040359,"marketCap":7444205719},{"date":"2021-12-17","current":-15.745339,"twenty":-33.487457,"median":-14.922795,"eighty":-10.083787,"marketCap":7654061092},{"date":"2021-12-23","current":-16.400947,"twenty":-33.487457,"median":-15.025245,"eighty":-10.107223,"marketCap":7972762612},{"date":"2021-12-31","current":-16.130464,"twenty":-33.487457,"median":-15.063476,"eighty":-10.131737,"marketCap":7841276465},{"date":"2022-01-07","current":-15.315432,"twenty":-33.486343,"median":-15.131066,"eighty":-10.17331,"marketCap":7445076489},{"date":"2022-01-14","current":-12.735991,"twenty":-33.486343,"median":-15.131066,"eighty":-10.19531,"marketCap":6191168869},{"date":"2022-01-21","current":-11.369245,"twenty":-33.486343,"median":-15.131066,"eighty":-10.240192,"marketCap":5526771985},{"date":"2022-01-28","current":-12.48342,"twenty":-33.486343,"median":-15.131066,"eighty":-10.273225,"marketCap":6068390415},{"date":"2022-02-04","current":-13.096038,"twenty":-33.486343,"median":-15.131066,"eighty":-10.298301,"marketCap":6366193474},{"date":"2022-02-11","current":-14.371428,"twenty":-33.486343,"median":-15.131066,"eighty":-10.376622,"marketCap":6986181131},{"date":"2022-02-18","current":-13.359356,"twenty":-33.486343,"median":-15.131066,"eighty":-10.466117,"marketCap":6494196544},{"date":"2022-02-25","current":-13.619091,"twenty":-33.486343,"median":-15.131066,"eighty":-10.518593,"marketCap":6620458075},{"date":"2022-03-04","current":-16.515095,"twenty":-33.486343,"median":-15.218077,"eighty":-10.572334,"marketCap":6916191383},{"date":"2022-03-11","current":-16.200858,"twenty":-33.486343,"median":-15.314536,"eighty":-10.632153,"marketCap":6784595503},{"date":"2022-03-18","current":-16.864709,"twenty":-33.486343,"median":-15.415744,"eighty":-10.710562,"marketCap":7062602692},{"date":"2022-03-25","current":-16.080158,"twenty":-33.486343,"median":-15.506708,"eighty":-10.766201,"marketCap":6734048742},{"date":"2022-04-01","current":-17.181026,"twenty":-33.486343,"median":-15.57248,"eighty":-10.834767,"marketCap":7195070067},{"date":"2022-04-08","current":-18.300623,"twenty":-33.486343,"median":-15.646479,"eighty":-10.859691,"marketCap":7663934856},{"date":"2022-04-14","current":-16.950031,"twenty":-33.486343,"median":-15.713597,"eighty":-10.886449,"marketCap":7098334024},{"date":"2022-04-22","current":-15.899108,"twenty":-33.486343,"median":-15.810262,"eighty":-10.922549,"marketCap":6658228599},{"date":"2022-04-29","current":-15.110477,"twenty":-33.486343,"median":-15.820202,"eighty":-10.969616,"marketCap":6327965648},{"date":"2022-05-06","current":-17.217729,"twenty":-33.486343,"median":-15.860447,"eighty":-11.021286,"marketCap":6139067423},{"date":"2022-05-13","current":-16.189475,"twenty":-33.486343,"median":-15.909513,"eighty":-11.07095,"marketCap":5772438397},{"date":"2022-05-20","current":-17.455774,"twenty":-33.486343,"median":-15.977123,"eighty":-11.111984,"marketCap":6223943355},{"date":"2022-05-27","current":-18.319605,"twenty":-33.486343,"median":-16.088482,"eighty":-11.170601,"marketCap":6531946738},{"date":"2022-06-03","current":-17.909776,"twenty":-33.486343,"median":-16.140631,"eighty":-11.179205,"marketCap":6385820133},{"date":"2022-06-10","current":-16.969868,"twenty":-33.486343,"median":-16.198799,"eighty":-11.221801,"marketCap":6050691453},{"date":"2022-06-17","current":-16.434882,"twenty":-33.486343,"median":-16.24212,"eighty":-11.287651,"marketCap":5859939358},{"date":"2022-06-24","current":-18.459487,"twenty":-33.487457,"median":-16.29347,"eighty":-11.319146,"marketCap":6581822286},{"date":"2022-07-01","current":-18.579736,"twenty":-33.487457,"median":-16.400947,"eighty":-11.396024,"marketCap":6624697757},{"date":"2022-07-08","current":-19.747872,"twenty":-33.487457,"median":-16.442244,"eighty":-11.453098,"marketCap":7041202331},{"date":"2022-07-15","current":-20.51354,"twenty":-33.487457,"median":-16.515095,"eighty":-11.483769,"marketCap":7314205329},{"date":"2022-07-22","current":-20.611703,"twenty":-33.487457,"median":-16.735684,"eighty":-11.570453,"marketCap":7349205714},{"date":"2022-07-29","current":-22.810546,"twenty":-33.487457,"median":-16.8079,"eighty":-11.586846,"marketCap":8133214324},{"date":"2022-08-05","current":-18.324864,"twenty":-33.487457,"median":-16.864709,"eighty":-11.632442,"marketCap":9283944199},{"date":"2022-08-12","current":-18.839938,"twenty":-33.487457,"median":-16.954193,"eighty":-11.749575,"marketCap":9544896413},{"date":"2022-08-19","current":-18.642896,"twenty":-33.487457,"median":-17.124838,"eighty":-11.790115,"marketCap":9445069056},{"date":"2022-08-26","current":-19.339455,"twenty":-33.487457,"median":-17.238255,"eighty":-11.839013,"marketCap":9797967519},{"date":"2022-09-02","current":-18.905618,"twenty":-33.487457,"median":-17.328348,"eighty":-11.85378,"marketCap":9578172198},{"date":"2022-09-09","current":-20.47158,"twenty":-33.487457,"median":-17.439311,"eighty":-11.869884,"marketCap":10371536983},{"date":"2022-09-16","current":-19.35674,"twenty":-33.487457,"median":-17.55145,"eighty":-11.869884,"marketCap":9806724305},{"date":"2022-09-23","current":-18.699934,"twenty":-33.487457,"median":-17.61038,"eighty":-11.869884,"marketCap":9473966448},{"date":"2022-09-30","current":-19.106117,"twenty":-33.487457,"median":-17.720715,"eighty":-11.882952,"marketCap":9679750912},{"date":"2022-10-07","current":-19.244391,"twenty":-33.487457,"median":-17.816521,"eighty":-11.882952,"marketCap":9749805198},{"date":"2022-10-14","current":-19.436248,"twenty":-33.487457,"median":-17.853332,"eighty":-11.882952,"marketCap":9847005519},{"date":"2022-10-21","current":-19.479458,"twenty":-33.487457,"median":-18.036331,"eighty":-11.882952,"marketCap":9868897483},{"date":"2022-10-28","current":-19.925395,"twenty":-33.487457,"median":-18.253383,"eighty":-11.882952,"marketCap":10094822554},{"date":"2022-11-04","current":-12.701188,"twenty":-33.487457,"median":-18.285586,"eighty":-11.882952,"marketCap":9096908350},{"date":"2022-11-11","current":-13.101968,"twenty":-33.487457,"median":-18.285586,"eighty":-11.882952,"marketCap":9383957374},{"date":"2022-11-18","current":-13.727039,"twenty":-33.487457,"median":-18.285586,"eighty":-11.882952,"marketCap":9831648512},{"date":"2022-11-25","current":-14.042026,"twenty":-33.487457,"median":-18.285586,"eighty":-11.882952,"marketCap":10057249732},{"date":"2022-12-02","current":-15.47356,"twenty":-33.487457,"median":-18.285586,"eighty":-11.882952,"marketCap":11082550220},{"date":"2022-12-09","current":-14.506539,"twenty":-33.487457,"median":-18.285586,"eighty":-11.882952,"marketCap":10389945695},{"date":"2022-12-16","current":-15.143866,"twenty":-33.487457,"median":-18.285586,"eighty":-11.882952,"marketCap":10846415090},{"date":"2022-12-23","current":-15.927042,"twenty":-33.487457,"median":-18.285586,"eighty":-11.882952,"marketCap":11407345751},{"date":"2022-12-30","current":-15.881694,"twenty":-33.487457,"median":-18.285586,"eighty":-11.882952,"marketCap":11374866198},{"date":"2023-01-06","current":-14.985759,"twenty":-33.487457,"median":-18.191555,"eighty":-11.882952,"marketCap":10733175567},{"date":"2023-01-13","current":-15.528713,"twenty":-33.456944,"median":-17.909776,"eighty":-11.882952,"marketCap":11122052379},{"date":"2023-01-20","current":-15.960134,"twenty":-33.300551,"median":-17.845559,"eighty":-11.882952,"marketCap":11431047046},{"date":"2023-01-27","current":-15.061748,"twenty":-32.919719,"median":-17.811613,"eighty":-11.882952,"marketCap":10787600764},{"date":"2023-02-03","current":-14.584979,"twenty":-31.722083,"median":-17.704757,"eighty":-11.882952,"marketCap":10446126544},{"date":"2023-02-10","current":-14.762695,"twenty":-30.985635,"median":-17.595871,"eighty":-11.882952,"marketCap":10573411279},{"date":"2023-02-17","current":-15.267654,"twenty":-29.901275,"median":-17.534969,"eighty":-11.882952,"marketCap":10935075492},{"date":"2023-02-24","current":-15.082584,"twenty":-29.05432,"median":-17.439311,"eighty":-11.882952,"marketCap":10802523802},{"date":"2023-03-03","current":-19.4614,"twenty":-28.510706,"median":-17.360065,"eighty":-11.882952,"marketCap":13690861124},{"date":"2023-03-10","current":-17.999387,"twenty":-28.077567,"median":-17.360065,"eighty":-11.882952,"marketCap":12662352889},{"date":"2023-03-17","current":-15.344252,"twenty":-27.752664,"median":-17.333332,"eighty":-11.882952,"marketCap":10794497470},{"date":"2023-03-24","current":-16.282242,"twenty":-27.473482,"median":-17.241552,"eighty":-11.882952,"marketCap":11454361608},{"date":"2023-03-31","current":-17.23774,"twenty":-27.348211,"median":-17.180972,"eighty":-11.887084,"marketCap":12126543209},{"date":"2023-04-06","current":-17.201471,"twenty":-27.162667,"median":-17.180972,"eighty":-11.887084,"marketCap":12101028462},{"date":"2023-04-14","current":-15.598135,"twenty":-26.652324,"median":-17.135243,"eighty":-11.882952,"marketCap":10973100697},{"date":"2023-04-21","current":-15.791986,"twenty":-26.082852,"median":-16.995814,"eighty":-11.882952,"marketCap":11109472618},{"date":"2023-04-28","current":-16.17049,"twenty":-25.551433,"median":-16.893792,"eighty":-11.882952,"marketCap":11375745723},{"date":"2023-05-05","current":-10.872457,"twenty":-25.030309,"median":-16.827533,"eighty":-11.85378,"marketCap":12125160030},{"date":"2023-05-12","current":-10.039712,"twenty":-24.79041,"median":-16.763727,"eighty":-11.839013,"marketCap":11196467970},{"date":"2023-05-19","current":-12.230575,"twenty":-24.588135,"median":-16.652443,"eighty":-11.832204,"marketCap":13639757112},{"date":"2023-05-26","current":-10.763039,"twenty":-24.230664,"median":-16.515095,"eighty":-11.806325,"marketCap":12003135296},{"date":"2023-06-02","current":-10.380495,"twenty":-24.049078,"median":-16.443073,"eighty":-11.77077,"marketCap":11576514470},{"date":"2023-06-09","current":-10.51664,"twenty":-23.8991,"median":-16.413486,"eighty":-11.709243,"marketCap":11728346773},{"date":"2023-06-16","current":-10.992733,"twenty":-23.737208,"median":-16.354855,"eighty":-11.607339,"marketCap":12259294089},{"date":"2023-06-23","current":-10.350426,"twenty":-23.536481,"median":-16.290064,"eighty":-11.554763,"marketCap":11542980955},{"date":"2023-06-30","current":-9.374853,"twenty":-23.474389,"median":-16.257046,"eighty":-11.479198,"marketCap":10455004700},{"date":"2023-07-07","current":-9.187757,"twenty":-23.38476,"median":-16.200858,"eighty":-11.461589,"marketCap":10246351720},{"date":"2023-07-14","current":-9.062469,"twenty":-23.039444,"median":-16.181079,"eighty":-11.394645,"marketCap":10106628742},{"date":"2023-07-21","current":-8.754262,"twenty":-22.805833,"median":-16.140052,"eighty":-11.314331,"marketCap":9762910216},{"date":"2023-07-28","current":-8.813564,"twenty":-22.54964,"median":-16.080158,"eighty":-11.279049,"marketCap":9829045759},{"date":"2023-08-04","current":-11.031997,"twenty":-22.46109,"median":-15.990696,"eighty":-11.220237,"marketCap":10013490129},{"date":"2023-08-11","current":-10.893262,"twenty":-22.365189,"median":-15.944171,"eighty":-11.17764,"marketCap":9887563612},{"date":"2023-08-18","current":-11.398874,"twenty":-22.213166,"median":-15.909513,"eighty":-11.172295,"marketCap":10346495809},{"date":"2023-08-25","current":-11.920929,"twenty":-22.033995,"median":-15.843668,"eighty":-11.172295,"marketCap":10820352632},{"date":"2023-09-01","current":-12.435789,"twenty":-21.874764,"median":-15.810262,"eighty":-11.172295,"marketCap":11287679931},{"date":"2023-09-07","current":-12.625908,"twenty":-21.804551,"median":-15.797541,"eighty":-11.172078,"marketCap":11460245899},{"date":"2023-09-15","current":-12.30322,"twenty":-21.692821,"median":-15.730942,"eighty":-11.171862,"marketCap":11167350147},{"date":"2023-09-22","current":-12.28575,"twenty":-21.543114,"median":-15.659417,"eighty":-11.171645,"marketCap":11151492734},{"date":"2023-09-29","current":-12.700927,"twenty":-21.385826,"median":-15.649721,"eighty":-11.170968,"marketCap":11528339498},{"date":"2023-10-06","current":-12.476896,"twenty":-21.308219,"median":-15.598135,"eighty":-11.170723,"marketCap":11324991491},{"date":"2023-10-13","current":-12.045276,"twenty":-21.147899,"median":-15.566211,"eighty":-11.170723,"marketCap":10933220103},{"date":"2023-10-20","current":-11.612629,"twenty":-21.079862,"median":-15.520133,"eighty":-11.170723,"marketCap":10540515926},{"date":"2023-10-23","current":-11.427649,"twenty":-21.068127,"median":-15.513919,"eighty":-11.170723,"marketCap":10372613902},{"date":"2023-11-03","current":-10.528937,"twenty":-20.936576,"median":-15.488267,"eighty":-11.099283,"marketCap":7274189914},{"date":"2023-11-10","current":-10.717147,"twenty":-20.877303,"median":-15.426491,"eighty":-11.063183,"marketCap":7404219801},{"date":"2023-11-17","current":-11.235741,"twenty":-20.779011,"median":-15.386996,"eighty":-11.038163,"marketCap":7762503589},{"date":"2023-11-24","current":-11.220846,"twenty":-20.664142,"median":-15.3405,"eighty":-11.038163,"marketCap":7752213454},{"date":"2023-12-01","current":-11.005556,"twenty":-20.59428,"median":-15.316056,"eighty":-11.023641,"marketCap":7603474231},{"date":"2023-12-08","current":-11.970979,"twenty":-20.499735,"median":-15.29952,"eighty":-11.023641,"marketCap":8270462067},{"date":"2023-12-14","current":-12.47197,"twenty":-20.414968,"median":-15.277459,"eighty":-11.022929,"marketCap":8616584786},{"date":"2023-12-22","current":-12.287822,"twenty":-20.322789,"median":-15.250912,"eighty":-11.014716,"marketCap":8489361300},{"date":"2023-12-29","current":-13.239705,"twenty":-20.231993,"median":-15.216098,"eighty":-11.011875,"marketCap":9146994468},{"date":"2024-01-05","current":-12.765795,"twenty":-20.179783,"median":-15.156008,"eighty":-11.010455,"marketCap":8819581084},{"date":"2024-01-12","current":-15.714872,"twenty":-20.100122,"median":-15.110477,"eighty":-11.010455,"marketCap":10857027796},{"date":"2024-01-19","current":-15.81507,"twenty":-19.947254,"median":-15.108301,"eighty":-11.009034,"marketCap":10926252340},{"date":"2024-01-26","current":-16.251068,"twenty":-19.907269,"median":-15.110477,"eighty":-11.010455,"marketCap":11227472653},{"date":"2024-02-02","current":-16.63155,"twenty":-19.806572,"median":-15.110477,"eighty":-11.010455,"marketCap":11490338827},{"date":"2024-02-09","current":-17.247634,"twenty":-19.70754,"median":-15.110477,"eighty":-11.010455,"marketCap":11915976225},{"date":"2024-02-16","current":-16.91048,"twenty":-19.657484,"median":-15.110477,"eighty":-11.010455,"marketCap":11683044990},{"date":"2024-02-23","current":-18.249616,"twenty":-19.552709,"median":-15.110477,"eighty":-11.010455,"marketCap":12608221665},{"date":"2024-03-01","current":-22.367193,"twenty":-19.518867,"median":-15.127171,"eighty":-11.011875,"marketCap":11988301184},{"date":"2024-03-08","current":-21.149893,"twenty":-19.518867,"median":-15.127171,"eighty":-11.011875,"marketCap":11335856419},{"date":"2024-03-15","current":-21.671724,"twenty":-19.518867,"median":-15.127171,"eighty":-11.011875,"marketCap":11615545541},{"date":"2024-03-22","current":-21.878355,"twenty":-19.518867,"median":-15.127171,"eighty":-11.011875,"marketCap":11726294925},{"date":"2024-03-28","current":-22.804691,"twenty":-19.518867,"median":-15.127171,"eighty":-11.011875,"marketCap":12222790044},{"date":"2024-04-05","current":-22.027199,"twenty":-19.511986,"median":-15.110477,"eighty":-11.010455,"marketCap":11806072023},{"date":"2024-04-12","current":-21.79255,"twenty":-19.511986,"median":-15.110477,"eighty":-11.010455,"marketCap":11680305774},{"date":"2024-04-19","current":-20.409174,"twenty":-19.511986,"median":-15.110477,"eighty":-11.010455,"marketCap":10938848035},{"date":"2024-04-26","current":-22.461914,"twenty":-19.518867,"median":-15.127171,"eighty":-11.011875,"marketCap":12039069403},{"date":"2024-05-03","current":730.75928,"twenty":-19.495389,"median":-15.100483,"eighty":-11.001542,"marketCap":12347639552},{"date":"2024-05-10","current":740.101452,"twenty":-19.445465,"median":-15.07282,"eighty":-10.973857,"marketCap":12505494241},{"date":"2024-05-17","current":742.562863,"twenty":-19.389234,"median":-15.060083,"eighty":-10.940505,"marketCap":12547084698},{"date":"2024-05-24","current":711.179876,"twenty":-19.347967,"median":-14.991274,"eighty":-10.914492,"marketCap":12016806371},{"date":"2024-05-31","current":696.187647,"twenty":-19.32434,"median":-14.923253,"eighty":-10.891058,"marketCap":11763482678},{"date":"2024-06-07","current":656.972899,"twenty":-19.250342,"median":-14.895006,"eighty":-10.871652,"marketCap":11100871079},{"date":"2024-06-14","current":699.264411,"twenty":-19.151885,"median":-14.846038,"eighty":-10.850764,"marketCap":11815470750},{"date":"2024-06-21","current":690.873238,"twenty":-19.114413,"median":-14.77176,"eighty":-10.837374,"marketCap":11673685101},{"date":"2024-06-28","current":883.646451,"twenty":-19.062416,"median":-14.738183,"eighty":-10.818876,"marketCap":14930974077},{"date":"2024-07-05","current":856.514992,"twenty":-19.012825,"median":-14.719798,"eighty":-10.773256,"marketCap":14472533812},{"date":"2024-07-12","current":850.920876,"twenty":-18.927625,"median":-14.62665,"eighty":-10.744454,"marketCap":14378010046},{"date":"2024-07-15","current":850.920876,"twenty":-18.908766,"median":-14.624593,"eighty":-10.731945,"marketCap":14378010046},{"date":"2024-08-02","current":805.608542,"twenty":-18.839555,"median":-14.506156,"eighty":-10.704978,"marketCap":13612367541},{"date":"2024-08-09","current":275.027337,"twenty":-18.813398,"median":-14.459064,"eighty":-10.653503,"marketCap":13007967957},{"date":"2024-08-16","current":268.857369,"twenty":-18.813398,"median":-14.360962,"eighty":-10.59605,"marketCap":12716146975},{"date":"2024-08-23","current":285.169474,"twenty":-18.813398,"median":-14.330229,"eighty":-10.577226,"marketCap":13487660617},{"date":"2024-08-30","current":276.741217,"twenty":-18.813398,"median":-14.330229,"eighty":-10.533579,"marketCap":13089029341},{"date":"2024-09-06","current":269.724391,"twenty":-18.813398,"median":-14.330229,"eighty":-10.51664,"marketCap":12757154499},{"date":"2024-09-13","current":252.726733,"twenty":-18.813398,"median":-14.330229,"eighty":-10.472775,"marketCap":11953216303},{"date":"2024-09-20","current":256.275473,"twenty":-18.813398,"median":-14.330229,"eighty":-10.409727,"marketCap":12121061051},{"date":"2024-09-27","current":251.718569,"twenty":-18.813398,"median":-14.330229,"eighty":-10.380495,"marketCap":11905533136},{"date":"2024-10-04","current":239.459285,"twenty":-18.813398,"median":-14.330229,"eighty":-10.355264,"marketCap":11325705825},{"date":"2024-10-11","current":246.818888,"twenty":-18.813398,"median":-14.330229,"eighty":-10.29911,"marketCap":11673792944},{"date":"2024-10-18","current":250.528934,"twenty":-18.813398,"median":-14.330229,"eighty":-10.273535,"marketCap":11849266999},{"date":"2024-10-25","current":266.195814,"twenty":-18.813398,"median":-14.330229,"eighty":-10.210207,"marketCap":12590263414},{"date":"2024-10-31","current":257.646577,"twenty":-18.813398,"median":-14.330229,"eighty":-10.148318,"marketCap":12185910158},{"date":"2024-11-08","current":94.40253,"twenty":-18.814187,"median":-14.33202,"eighty":-10.124434,"marketCap":11502476253},{"date":"2024-11-15","current":85.536124,"twenty":-18.814187,"median":-14.33202,"eighty":-10.081418,"marketCap":10422149011},{"date":"2024-11-22","current":86.625806,"twenty":-18.814187,"median":-14.33202,"eighty":-10.039712,"marketCap":10554921325},{"date":"2024-11-29","current":104.531086,"twenty":-18.814187,"median":-14.33202,"eighty":-9.994314,"marketCap":12736590131},{"date":"2024-12-06","current":98.996441,"twenty":-18.814187,"median":-14.33202,"eighty":-9.880803,"marketCap":12062221402},{"date":"2024-12-13","current":97.577503,"twenty":-18.814187,"median":-14.33202,"eighty":-9.825179,"marketCap":11889330835},{"date":"2024-12-20","current":93.657783,"twenty":-18.814187,"median":-14.236415,"eighty":-9.703473,"marketCap":11411732585},{"date":"2024-12-27","current":96.715165,"twenty":-18.814187,"median":-14.1595,"eighty":-9.485199,"marketCap":11784259220},{"date":"2025-01-03","current":97.279604,"twenty":-18.814187,"median":-14.062861,"eighty":-9.459492,"marketCap":11853033368},{"date":"2025-01-10","current":98.988602,"twenty":-18.814976,"median":-13.918522,"eighty":-9.374471,"marketCap":12061266205},{"date":"2025-01-17","current":91.768478,"twenty":-18.814976,"median":-13.725814,"eighty":-9.290713,"marketCap":11181530229},{"date":"2025-01-24","current":93.399082,"twenty":-18.814976,"median":-13.6749,"eighty":-9.174719,"marketCap":11380211101},{"date":"2025-01-31","current":89.722385,"twenty":-18.814976,"median":-13.611926,"eighty":-9.085121,"marketCap":10932223942},{"date":"2025-02-07","current":87.887956,"twenty":-18.814976,"median":-13.459852,"eighty":-9.049606,"marketCap":10708707961},{"date":"2025-02-14","current":85.810504,"twenty":-18.814976,"median":-13.307151,"eighty":-9.020125,"marketCap":10455580889},{"date":"2025-02-21","current":84.987363,"twenty":-18.814976,"median":-13.243105,"eighty":-8.988436,"marketCap":10355285256},{"date":"2025-02-28","current":42.452846,"twenty":-18.814976,"median":-13.154716,"eighty":-8.920632,"marketCap":9986565117},{"date":"2025-03-07","current":43.541699,"twenty":-18.815765,"median":-13.180128,"eighty":-8.825258,"marketCap":10242705625},{"date":"2025-03-14","current":40.575946,"twenty":-18.815765,"median":-13.180128,"eighty":-8.721628,"marketCap":9545045021},{"date":"2025-03-21","current":30.296872,"twenty":-18.815765,"median":-13.180128,"eighty":-8.592569,"marketCap":7127005761},{"date":"2025-03-28","current":29.6204,"twenty":-18.815765,"median":-13.180128,"eighty":-8.512782,"marketCap":6967873162},{"date":"2025-04-04","current":24.175625,"twenty":-18.815765,"median":-13.180128,"eighty":-8.405114,"marketCap":5687049798},{"date":"2025-04-11","current":20.752016,"twenty":-18.814976,"median":-13.154716,"eighty":-8.268659,"marketCap":4881683592},{"date":"2025-04-17","current":22.249329,"twenty":-18.814976,"median":-13.154716,"eighty":-8.114977,"marketCap":5233910017},{"date":"2025-04-25","current":25.474946,"twenty":-18.815765,"median":-13.129304,"eighty":-7.839802,"marketCap":5992700828},{"date":"2025-05-02","current":26.222557,"twenty":-18.815765,"median":-13.101968,"eighty":-7.764774,"marketCap":6168568056},{"date":"2025-05-09","current":-14.449479,"twenty":-18.815765,"median":-13.101968,"eighty":-7.70856,"marketCap":3589077208},{"date":"2025-05-16","current":-13.954905,"twenty":-18.815765,"median":-13.101968,"eighty":-7.70856,"marketCap":3466230918},{"date":"2025-05-23","current":-15.347626,"twenty":-18.815765,"median":-13.101968,"eighty":-7.70856,"marketCap":3812166071},{"date":"2025-05-30","current":-15.276407,"twenty":-18.815765,"median":-13.101968,"eighty":-7.70856,"marketCap":3794476205},{"date":"2025-06-06","current":-15.513803,"twenty":-18.815765,"median":-13.101968,"eighty":-7.70856,"marketCap":3853442424},{"date":"2025-06-13","current":-14.76205,"twenty":-18.786702,"median":-13.101968,"eighty":-7.70856,"marketCap":3666716063},{"date":"2025-06-20","current":-8.217844,"twenty":-18.714796,"median":-13.033893,"eighty":-7.695186,"marketCap":2041213954},{"date":"2025-06-27","current":-6.81721,"twenty":-18.637179,"median":-12.845744,"eighty":-7.550572,"marketCap":1693313261},{"date":"2025-07-03","current":-7.216826,"twenty":-18.58593,"median":-12.755864,"eighty":-7.468209,"marketCap":1792573063},{"date":"2025-07-11","current":-7.543245,"twenty":-18.495182,"median":-12.728199,"eighty":-7.216826,"marketCap":1873651615},{"date":"2025-07-18","current":-8.692636,"twenty":-18.402876,"median":-12.685873,"eighty":-7.192295,"marketCap":2159146393},{"date":"2025-07-25","current":-5.096092,"twenty":-18.337103,"median":-12.588811,"eighty":-6.824332,"marketCap":1265808172},{"date":"2025-08-01","current":-6.496726,"twenty":-18.323531,"median":-12.502567,"eighty":-6.309975,"marketCap":1613708865},{"date":"2025-08-08","current":-30.280443,"twenty":-18.278392,"median":-12.480158,"eighty":-6.269618,"marketCap":1754933346},{"date":"2025-08-15","current":-34.225668,"twenty":-18.278392,"median":-12.480158,"eighty":-6.269618,"marketCap":1983582791},{"date":"2025-08-22","current":-33.821029,"twenty":-18.278392,"median":-12.480158,"eighty":-6.269618,"marketCap":1960131566},{"date":"2025-08-29","current":-31.099468,"twenty":-18.278392,"median":-12.480158,"eighty":-6.269618,"marketCap":1802400766},{"date":"2025-09-05","current":-31.302954,"twenty":-18.249616,"median":-12.476896,"eighty":-6.263287,"marketCap":1814194010},{"date":"2025-09-12","current":-30.370309,"twenty":-18.278392,"median":-12.480158,"eighty":-6.269618,"marketCap":1760141643},{"date":"2025-09-19","current":-31.224599,"twenty":-18.278392,"median":-12.480158,"eighty":-6.269618,"marketCap":1809652871},{"date":"2025-09-26","current":-29.875804,"twenty":-18.278392,"median":-12.480158,"eighty":-6.269618,"marketCap":1731482121},{"date":"2025-10-03","current":-37.681954,"twenty":-18.278392,"median":-12.480158,"eighty":-6.269618,"marketCap":2183895339},{"date":"2025-10-10","current":-38.997029,"twenty":-18.278392,"median":-12.480158,"eighty":-6.269618,"marketCap":2260111820},{"date":"2025-10-17","current":-39.351088,"twenty":-18.278392,"median":-12.480158,"eighty":-6.269618,"marketCap":2280631642},{"date":"2025-10-24","current":-36.906397,"twenty":-18.278392,"median":-12.480158,"eighty":-6.269618,"marketCap":2138947157},{"date":"2025-10-31","current":-39.199348,"twenty":-18.278392,"median":-12.480158,"eighty":-6.269618,"marketCap":2271837433},{"date":"2025-11-07","current":-6.807921,"twenty":-18.223927,"median":-12.457149,"eighty":-6.253485,"marketCap":1848445978},{"date":"2025-11-14","current":-6.87739,"twenty":-18.189834,"median":-12.430906,"eighty":-6.253485,"marketCap":1867307672},{"date":"2025-11-21","current":-6.360235,"twenty":-18.104827,"median":-12.316985,"eighty":-6.253485,"marketCap":1726892841},{"date":"2025-11-28","current":-8.235887,"twenty":-18.028942,"median":-12.303652,"eighty":-6.253485,"marketCap":2236158570},{"date":"2025-12-05","current":-8.807073,"twenty":-17.855116,"median":-12.257687,"eighty":-6.253485,"marketCap":2391243607},{"date":"2025-12-12","current":-8.394121,"twenty":-17.795907,"median":-12.229083,"eighty":-6.253485,"marketCap":2279121317},{"date":"2025-12-19","current":-7.84995,"twenty":-17.574187,"median":-12.171314,"eighty":-6.253485,"marketCap":2131371383},{"date":"2025-12-26","current":-8.614105,"twenty":-17.527474,"median":-12.140846,"eighty":-6.253485,"marketCap":2338850013},{"date":"2026-01-02","current":-8.305355,"twenty":-17.389271,"median":-12.109685,"eighty":-6.253485,"marketCap":2255020264},{"date":"2026-01-09","current":-8.934432,"twenty":-17.297567,"median":-12.067761,"eighty":-6.253485,"marketCap":2425823379},{"date":"2026-01-16","current":-8.224309,"twenty":-17.297567,"median":-12.067761,"eighty":-6.253485,"marketCap":2233014954},{"date":"2026-01-23","current":-8.409558,"twenty":-17.297567,"median":-11.974925,"eighty":-6.253485,"marketCap":2283312804},{"date":"2026-01-30","current":-8.195363,"twenty":-17.297567,"median":-11.969206,"eighty":-6.253485,"marketCap":2225155915},{"date":"2026-02-06","current":-6.5725,"twenty":-17.297567,"median":-11.948844,"eighty":-6.253485,"marketCap":1784525794},{"date":"2026-02-13","current":-6.715297,"twenty":-17.297567,"median":-11.916683,"eighty":-6.253485,"marketCap":1823297053},{"date":"2026-02-20","current":-7.174561,"twenty":-17.297567,"median":-11.904224,"eighty":-6.253485,"marketCap":1947993806},{"date":"2026-02-27","current":-2.563093,"twenty":-17.297567,"median":-11.904224,"eighty":-5.500851,"marketCap":1828536413},{"date":"2026-03-06","current":-2.388506,"twenty":-17.297567,"median":-11.803301,"eighty":-4.795391,"marketCap":1703983999},{"date":"2026-03-13","current":-2.50771,"twenty":-17.297567,"median":-11.687134,"eighty":-2.567763,"marketCap":1789025714},{"date":"2026-03-20","current":-2.450316,"twenty":-17.297567,"median":-11.574408,"eighty":-2.459666,"marketCap":1748079703},{"date":"2026-03-27","current":-3.190561,"twenty":-17.297567,"median":-11.560932,"eighty":-2.456791,"marketCap":2276178256},{"date":"2026-04-02","current":-3.256786,"twenty":-17.297567,"median":-11.560932,"eighty":-2.456791,"marketCap":2323423654},{"date":"2026-04-10","current":-3.271503,"twenty":-17.297567,"median":-11.560932,"eighty":-2.456791,"marketCap":2333922631},{"date":"2026-04-17","current":-3.115506,"twenty":-17.297567,"median":-11.560932,"eighty":-2.456791,"marketCap":2222633473},{"date":"2026-04-24","current":-3.005132,"twenty":-17.297567,"median":-11.560932,"eighty":-2.456791,"marketCap":2143891144},{"date":"2026-05-01","current":-3.072828,"twenty":-17.297567,"median":-11.560932,"eighty":-2.456791,"marketCap":2192186439},{"date":"2026-05-08","current":33.754791,"twenty":-17.297567,"median":-11.560932,"eighty":-2.45061,"marketCap":2195985417},{"date":"2026-05-15","current":30.314399,"twenty":-17.297567,"median":-11.560932,"eighty":-2.342001,"marketCap":1972163826},{"date":"2026-05-22","current":27.523137,"twenty":-17.297567,"median":-11.560932,"eighty":22.072787,"marketCap":1790572725},{"date":"2026-05-29","current":28.074898,"twenty":-17.31005,"median":-11.569868,"eighty":22.533943,"marketCap":1826468640},{"date":"2026-06-05","current":27.036289,"twenty":-17.297567,"median":-11.560932,"eighty":24.523761,"marketCap":1758899858},{"date":"2026-06-12","current":24.342397,"twenty":-17.297567,"median":-11.560932,"eighty":25.34445,"marketCap":1583643330},{"date":"2026-06-18","current":27.523137,"twenty":-17.297567,"median":-11.560932,"eighty":25.524444,"marketCap":1790572725},{"date":"2026-06-26","current":25.99768,"twenty":-17.31005,"median":-11.569868,"eighty":25.786713,"marketCap":1691331076},{"date":"2026-07-02","current":29.535442,"twenty":-17.31005,"median":-11.569868,"eighty":26.324661,"marketCap":1921487240},{"date":"2026-07-10","current":33.300399,"twenty":-17.31005,"median":-11.569868,"eighty":27.003833,"marketCap":2166424075},{"date":"2026-07-17","current":27.9613,"twenty":-17.31005,"median":-11.569868,"eighty":27.263485,"marketCap":1819078305},{"date":"2026-07-24","current":25.770484,"twenty":-17.31005,"median":-11.569868,"eighty":27.344626,"marketCap":1676550405},{"date":"2026-07-31","current":25.25118,"twenty":-17.312547,"median":-11.574408,"eighty":27.380328,"marketCap":1642766014},{"date":"2026-08-07","current":-12.963404,"twenty":-17.312547,"median":-11.625362,"eighty":27.380328,"marketCap":1772421412},{"date":"2026-08-14","current":-14.230387,"twenty":-17.312547,"median":-11.704605,"eighty":27.380328,"marketCap":1945649726},{"date":"2026-08-21","current":-14.848428,"twenty":-17.312547,"median":-11.894316,"eighty":27.380328,"marketCap":2030151343},{"date":"2026-08-28","current":-16.679374,"twenty":-17.312547,"median":-11.967505,"eighty":27.380328,"marketCap":2280487383}],"updateTime":1788245146527},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SRPT\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2648902564","title":"Sarepta Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2648902564","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648902564?lang=en_us&edition=fundamental","pubTime":"2026-07-01 04:25","pubTimestamp":1782851100,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nTUAGDQYV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","SRPT","IE0009355771.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","IE0002141913.USD","SRPU","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648563682","title":"Sarepta Shares up on FDA Acceptance of Supplemental New Drug Applications","url":"https://stock-news.laohu8.com/highlight/detail?id=2648563682","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648563682?lang=en_us&edition=fundamental","pubTime":"2026-07-01 00:38","pubTimestamp":1782837480,"startTime":"0","endTime":"0","summary":"Shares of Sarepta Therapeutics rose after the Food and Drug Administration accepted the company's supplemental new drug applications for two treatments for Duchenne muscular dystrophy.The stock gained 5.4% to $17.93 in midday trading on Tuesday. Shares are down 17% this year.Sarepta said the FDA has assigned a Prescription Drug User Fee Act target action data of Feb. 28, 2027 for the treatments, Amondys 45 and Vyondys 53.The submissions seek to convert the accelerated approvals of the drugs to traditional approvals, the company said.Analysts at Mizuho view the FDA filing acceptance as positive news, given investor concerns that the regulatory path forward could be limited after a Phase 3 trial evaluating the treatments failed to achieve statistical significance.\"We continue to believe the risk of Amondys 45/Vyondys 53 being withdrawn from the market remains low, given the clinical benefits demonstrated with real-world evidence and the ultra-rare nature of the exon 45 and exon 53 amenab","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","BK4585","SRPU","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","IE0009355771.USD","IE00BJJMRZ35.SGD","SRPT","BK4139","IE00B2B36J28.USD","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647355905","title":"Sarepta Therapeutics Gets FDA Review for Duchenne Muscular Dystrophy Applications","url":"https://stock-news.laohu8.com/highlight/detail?id=2647355905","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647355905?lang=en_us&edition=fundamental","pubTime":"2026-06-30 21:18","pubTimestamp":1782825508,"startTime":"0","endTime":"0","summary":"Sarepta Therapeutics  said Tuesday the US Food and Drug Administration has accepted its supplemental new drug applications for two treatments targeting Duchenne muscular dystrophy.The regulator established a target action date of Feb. 28, 2027, to complete its evaluation of both Amondys 45 and Vyondys 53, the company said.The company submitted the requests to transition the medical products from accelerated to standard approvals.Shares of the company rose more than 3% in Tuesday premarket activity.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SRPT","BK4588","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","BK4585","IE0002141913.USD","BK4139","IE0009355771.USD","LABU","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","SRPU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647555730","title":"Sarepta Says FDA Accepts Amondys 45, Vyondys 53 Sndas for Review, Sets Feb. 28, 2027 PDUFA Date","url":"https://stock-news.laohu8.com/highlight/detail?id=2647555730","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647555730?lang=en_us&edition=fundamental","pubTime":"2026-06-30 20:30","pubTimestamp":1782822645,"startTime":"0","endTime":"0","summary":"Sarepta says FDA accepts AMONDYS 45, VYONDYS 53 sNDAs for review, sets Feb. 28, 2027 PDUFA dateSarepta Therapeutics’ sNDAs for AMONDYS 45, VYONDYS 53 accepted by FDA for review to convert accelerated ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nNDL51svWH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SRPU","SRPT","IE0009355771.USD","IE00B2B36J28.USD","BK4139","IE0002141913.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","BK4585","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647555789","title":"Sarepta Therapeutics - FDA Sets Pdufa Target Action Date of February 28, 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2647555789","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647555789?lang=en_us&edition=fundamental","pubTime":"2026-06-30 20:30","pubTimestamp":1782822601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nTUA33JKJS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BJT1NW94.SGD","IE0002141913.USD","SRPU","IE00BJJMRZ35.SGD","IE0009355771.USD","SRPT","BK4585","BK4139","IE00BFTCPJ56.SGD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647555274","title":"Sarepta Announces FDA Acceptance of Sndas for Amondys 45® and Vyondys 53®","url":"https://stock-news.laohu8.com/highlight/detail?id=2647555274","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647555274?lang=en_us&edition=fundamental","pubTime":"2026-06-30 20:30","pubTimestamp":1782822601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nTUA33JKJS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","IE0009355771.USD","IE0002141913.USD","IE00BJT1NW94.SGD","SRPU","SRPT","IE00BJJMRZ35.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645604056","title":"Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT), Eli Lilly & Co (LLY) and C4 Therapeutics (CCCC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2645604056","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645604056?lang=en_us&edition=fundamental","pubTime":"2026-06-22 16:41","pubTimestamp":1782117698,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sarepta Therapeutics (SRPT), Eli Lilly & Co (LLY) ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-sarepta-therapeutics-srpt-eli-lilly-co-lly-and-c4-therapeutics-cccc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-sarepta-therapeutics-srpt-eli-lilly-co-lly-and-c4-therapeutics-cccc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ELIS","LU2028103732.USD","LU1868836591.USD","BK4007","SG9999013999.USD","LU2361044865.SGD","BK4139","IE00BFTCPJ56.SGD","LU0061475181.USD","LU2108987350.USD","LU1551013342.USD","LU1712237335.SGD","LU2112291526.USD","LU0432979614.USD","LU0109394709.USD","LLY","LU1093756325.SGD","LU2089283258.USD","LU2491049909.HKD","IE00BK4W5L77.USD","LU0820562030.AUD","LU2023250330.USD","SG9999018865.SGD","SGXZ57979304.SGD","LU2237443622.USD","LLYX","LU2237443549.SGD","LU2265009873.SGD","LU2089984988.USD","LU0787776722.HKD","LU2237443465.HKD","LU0323591593.USD","LU2417539215.USD","IE00B4R5TH58.HKD","SG9999014880.SGD","LU2491050071.SGD","LU0158827948.USD","LU2471134952.CNY","LU1720051017.SGD","SG9999014898.SGD","SRPT","LU2087625088.SGD","LU2271345857.HKD","LU0289739699.SGD","LU0133085943.USD","IE0009355771.USD","BK4599","SGXZ31699556.SGD","LU0320765059.SGD","LU0353189763.USD","IE00BN29S564.USD","LU0203201768.USD","LU0786609619.USD","LU1814569148.SGD","IE00BKPKM429.USD","GB00BDT5M118.USD","SG9999015952.SGD","LU1548497426.USD","LU1267930730.SGD","IE00BK4W5M84.HKD","IE00BJJMRY28.SGD","LU1989771016.USD","LU0353189680.USD","LU2089284900.SGD","LU0466842654.USD","LU0882574055.USD","LU2023250504.SGD","LU0385154629.USD","LU1868836757.USD","LU2168564149.EUR","BK4588","LU0006306889.USD","LU0354030511.USD","LU1623119135.USD","LU2461242641.AUD","SGXZ81514606.USD","LU2602419157.SGD","LU1366192091.USD","LU0256863811.USD","LU0689472784.USD","LU0943347566.SGD","LU0882574139.USD","SG9999017495.SGD","LU0820561818.USD","LU0823434583.USD","LU0158827781.USD","IE0004445015.USD","LU0708995401.HKD","LU0210536198.USD","BK4585","SG9999015978.USD","BK4516","LU0417517546.SGD","LU2168563687.JPY","LU1127390331.HKD","IE00BFSS8Q28.SGD","LU0820561909.HKD","SG9999014906.USD","LU2237438978.USD","IE00B7KXQ091.USD","LU0234572021.USD","LU1868837136.USD","LU2361045086.USD","LU2746668974.SGD","LU0683600562.USD","LU2552382215.SGD","LU1035775433.USD","LU0079474960.USD","IE0002141913.USD","LU0203202063.USD","IE00BJJMRZ35.SGD","SG9999015945.SGD","LU2552382132.HKD","LU2168564065.EUR","CCCC","LU0640476718.USD","LU2471134523.USD","LU1988902786.USD","IE00B1BXHZ80.USD","LU2361044949.HKD","IE0001KFT4U8.USD","LU0316494557.USD","IE0004445239.USD","IE00BWXC8680.SGD","LU1280957306.USD","LU2746668461.USD","LU0456855351.SGD","LU2236285917.USD","LU2552382058.USD","IE00B775H168.HKD","LU2750360997.AUD","LU1868836914.USD","LU2168564222.USD","LU2491050154.USD","IE00BFSS7M15.SGD","BK4533","LU2063271972.USD","LU2896262040.SGD","IE00B2B36J28.USD","LU2324357040.USD","LU0225283273.USD","LU1061106388.HKD","LU1291159041.SGD","LU2213496289.HKD","LU2237443895.HKD","LU0058720904.USD","LU2168564495.EUR","LU0106261372.USD","LU2360106947.USD","LU1804176565.USD","LU2756315318.SGD","LU1057294990.SGD","LU1868837300.USD","LU2756315664.SGD","LU0964807845.USD","LU0238689110.USD","IE00B4JS1V06.HKD","SG9999018857.SGD","LU2237443978.SGD","LU2468319806.SGD","LU2456880835.USD","SG9999001176.USD","LU1023059063.AUD","SGXZ99366536.SGD","IE00BKDWB100.SGD","LU2237443382.USD","BK4581","ELIL","LU1974910355.USD","LU0823416689.USD","BK4534","LU0097036916.USD","LU2357305700.SGD","LU1551013425.SGD","IE00BJJMRX11.SGD","LU2211815571.USD","IE00BJT1NW94.SGD","LU0889565916.HKD","LU0114720955.EUR","SG9999015986.USD","SRPU","LU2023251221.USD","IE0005OL40V9.USD","SG9999001176.SGD","LU0471298777.SGD","LU2106854487.HKD","LU0122379950.USD","LU0471298694.HKD","LU1323610961.USD","LU0672654240.SGD","LU0198837287.USD","LU0354030438.USD","LU1917777945.USD","LU2111349929.HKD","LLII","LLYZ","LU2471134879.HKD","LU1983299246.USD","IE00B1XK9C88.USD","LU2471134796.USD","LU1064131342.USD","IE00BJLML261.HKD","LU0096364046.USD","LU0320765992.SGD","LU1232071149.USD","LU0256863902.USD","SGXZ51526630.SGD","LU1720051108.HKD","LU0094547139.USD","LU1069344957.HKD","SG9999014914.USD","LU1093756168.USD","LU2462157665.USD","LU2750360641.GBP","LU1629891620.HKD","LU0266013472.USD","LU1145028129.USD","LU2264538146.SGD","LU0823434740.USD","LU0109391861.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645040374","title":"Barclays Sticks to Its Hold Rating for Sarepta Therapeutics (SRPT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2645040374","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645040374?lang=en_us&edition=fundamental","pubTime":"2026-06-22 16:41","pubTimestamp":1782117665,"startTime":"0","endTime":"0","summary":"In a report released today, Eliana Merle from Barclays maintained a Hold rating on Sarepta Therapeutics, with a price target of $20.00. Merle cover...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/barclays-sticks-to-its-hold-rating-for-sarepta-therapeutics-srpt-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/barclays-sticks-to-its-hold-rating-for-sarepta-therapeutics-srpt-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SRPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645401860","title":"Sarepta Therapeutics (SRPT) Stock Could Be 19% Undervalued As Elevidys Outlook Steadies","url":"https://stock-news.laohu8.com/highlight/detail?id=2645401860","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645401860?lang=en_us&edition=fundamental","pubTime":"2026-06-21 22:19","pubTimestamp":1782051542,"startTime":"0","endTime":"0","summary":"Recent commentary around Sarepta Therapeutics (SRPT) focuses on Elevidys, its gene therapy for Duchenne muscular dystrophy, with expectations of near term stabilization and renewed attention on the company’s siRNA pipeline and the evolving FDA stance.\nSee our latest analysis for Sarepta Therapeutics.\nThe recent focus on Elevidys and Sarepta Therapeutics’ siRNA programs comes after a mixed share price record, with a 14.5% 7 day share price return and year to date share price performance down...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-srpt/sarepta-therapeutics/news/sarepta-therapeutics-srpt-stock-could-be-19-undervalued-as-e","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-srpt/sarepta-therapeutics/news/sarepta-therapeutics-srpt-stock-could-be-19-undervalued-as-e","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SRPU","BK4585","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","IE0009355771.USD","IE00B2B36J28.USD","BK4139","IE00BJT1NW94.SGD","SRPT","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644569082","title":"Sarepta's Elevidys Showing Signs of Stabilization as siRNA Pipeline Gains Importance, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2644569082","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644569082?lang=en_us&edition=fundamental","pubTime":"2026-06-18 23:04","pubTimestamp":1781795083,"startTime":"0","endTime":"0","summary":"Sarepta Therapeutics' (SRPT) Elevidys for Duchenne muscular dystrophy shows near-term stabilization, while the company's $800 million to $900 million operating expense base provides reassuring visibil","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4505","BK4139","BK4563","SLDB","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","IE0009355771.USD","IE0002141913.USD","IE00BJT1NW94.SGD","SRPU","SRPT","RGNX","IE00BJJMRZ35.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641483223","title":"Is Sarepta Therapeutics (SRPT) Quietly Rewriting Its Risk Profile With New Equity Plans And Q1 Profitability?","url":"https://stock-news.laohu8.com/highlight/detail?id=2641483223","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641483223?lang=en_us&edition=fundamental","pubTime":"2026-06-08 17:15","pubTimestamp":1780910139,"startTime":"0","endTime":"0","summary":"Sarepta Therapeutics recently filed a US$341.998057 million shelf registration for 7,786,841 common shares tied to employee stock plans, and shareholders approved new 2026 equity and employee stock purchase plans, while the company returned to profitability in the first quarter of 2026 despite weaker ELEVIDYS sales. \nThese moves suggest Sarepta is reinforcing its balance sheet flexibility and employee ownership just as disciplined cost control supports a profitable, self-funded pipeline...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-srpt/sarepta-therapeutics/news/is-sarepta-therapeutics-srpt-quietly-rewriting-its-risk-prof","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-srpt/sarepta-therapeutics/news/is-sarepta-therapeutics-srpt-quietly-rewriting-its-risk-prof","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4215","IE00BJT1NW94.SGD","EQR","BK4588","IE0009355771.USD","SRPU","IE00B2B36J28.USD","IE0002141913.USD","IE00BFTCPJ56.SGD","SRPT","BK4139","BK4585","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641125280","title":"A Look At Sarepta Therapeutics (SRPT) Valuation After New Shelf Registration For Potential Share Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2641125280","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641125280?lang=en_us&edition=fundamental","pubTime":"2026-06-06 09:17","pubTimestamp":1780708670,"startTime":"0","endTime":"0","summary":"Sarepta Therapeutics (SRPT) has filed a shelf registration for up to US$342 million in common shares, tied to an ESOP related offering, which puts potential share issuance and future capital needs in focus for investors.\nSee our latest analysis for Sarepta Therapeutics.\nThe shelf registration lands after a difficult stretch for holders, with the share price down 31.61% over the last month and the 1 year total shareholder return falling 63.38%. This suggests sentiment has weakened despite...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-srpt/sarepta-therapeutics/news/a-look-at-sarepta-therapeutics-srpt-valuation-after-new-shel","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-srpt/sarepta-therapeutics/news/a-look-at-sarepta-therapeutics-srpt-valuation-after-new-shel","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00BJT1NW94.SGD","IE0009355771.USD","SRPU","IE00B2B36J28.USD","IE0002141913.USD","IE00BFTCPJ56.SGD","SRPT","BK4139","BK4585","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641620931","title":"Sarepta Therapeutics shareholders approve 2026 equity incentive plan at annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2641620931","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641620931?lang=en_us&edition=fundamental","pubTime":"2026-06-05 04:31","pubTimestamp":1780605077,"startTime":"0","endTime":"0","summary":"Sarepta Therapeutics held its annual shareholder meeting on June 4, 2026.Shareholders adopted a 2026 Equity Incentive Plan, replacing the 2018 plan; up to 6,286,841 shares may be issued under awards.Shareholders adopted a 2026 Employee Stock Purchase Plan, replacing the 2013 plan; 1,500,000 shares will be available for issuance.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sarepta Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 04, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDL97s6WL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","IE0009355771.USD","IE00BJJMRZ35.SGD","SRPU","BK4585","SRPT","IE00B2B36J28.USD","IE0002141913.USD","IE00BJT1NW94.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641662169","title":"SRPT Expands Into Huntington’s Disease With New First-in-Human Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2641662169","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641662169?lang=en_us&edition=fundamental","pubTime":"2026-06-05 00:34","pubTimestamp":1780590866,"startTime":"0","endTime":"0","summary":"Sarepta Therapeutics Inc. ($SRPT) announced an update on their ongoing clinical study. Sarepta Therapeutics, Inc. (SRPT) has launched a first in hu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/srpt-expands-into-huntingtons-disease-with-new-first-in-human-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/srpt-expands-into-huntingtons-disease-with-new-first-in-human-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","IE00BJT1NW94.SGD","IE0009355771.USD","IE00BFTCPJ56.SGD","BK4139","SRPU","IE00BJJMRZ35.SGD","SRPT","IE00B2B36J28.USD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640189582","title":"Acting US FDA chief meets with rare disease groups to mend fences","url":"https://stock-news.laohu8.com/highlight/detail?id=2640189582","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640189582?lang=en_us&edition=fundamental","pubTime":"2026-06-04 03:10","pubTimestamp":1780513809,"startTime":"0","endTime":"0","summary":"Acting US FDA chief meets with rare disease groups to mend fencesRare disease groups seek regulatory clarity from FDA officialsDecisions by previous FDA chief disappointed such groupsActing commissioner seen as potential permanent nominee, sources sayBy Chris Prentice. 'SIGNIFICANT UNMET NEED'\"Meetings like this demonstrate FDA's continued commitment to address the real challenges facing the rare disease community and to advancing treatments in small-patient populations,\" Jeff Allen, CEO of Friends of Cancer Research, said in a statement.He said there were opportunities for novel trial designs and more efficient clinical trials, \"which could help accelerate new therapies to address areas of significant unmet need.\"A spokesperson for the Foundation for Angelman Syndrome Therapeutics, an advocacy group for patients with a rare neuro-genetic disorder, also confirmed attending the meeting. For diseases with small patient populations, regulatory clarity is needed to overcome challenges incl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nL6N42B0TA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756325.SGD","SRPU","BHVN","BK4585","IE00BJJMRZ35.SGD","LU1093756168.USD","IE00BFTCPJ56.SGD","IE0009355771.USD","IE00B2B36J28.USD","BK4139","IE00BJT1NW94.SGD","SRPT","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640596470","title":"Sarepta Therapeutics to present at Goldman Sachs Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2640596470","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640596470?lang=en_us&edition=fundamental","pubTime":"2026-06-02 04:30","pubTimestamp":1780345841,"startTime":"0","endTime":"0","summary":"Sarepta Therapeutics management is scheduled to appear at the Goldman Sachs 47th Annual Global Healthcare Conference on June 8, 2026.The event includes a fireside chat at 10:40 a.m. ET in Miami Beach, Florida.Management is also set for investor meetings at the Oppenheimer CNS and Neuro-Muscular Summit on June 10, 2026 in Miami Beach.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sarepta Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on June 01, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDL81QQww:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0034235188.USD","IE0002141913.USD","BK4516","LU0742534661.SGD","BK4127","LU1894683348.USD","LU0345770993.USD","LU1868836757.USD","LU0106831901.USD","BK4585","LU2237443622.USD","LU1894683264.USD","LU1868836914.USD","SRPT","LU2471134796.USD","LU0096364046.USD","IE00B19Z3B42.SGD","LU2750360641.GBP","GSX","IE0004086264.USD","LU0251142724.SGD","LU2237438978.USD","LU2237443978.SGD","LU0942090050.USD","LU1868837300.USD","IE00BJT1NW94.SGD","LU2237443895.HKD","LU2750360997.AUD","LU0345770308.USD","LU0868494617.USD","LU1868837136.USD","LU2237443549.SGD","LU1791807156.HKD","IE00BFXG1179.USD","LU0048573561.USD","LU0251131958.USD","LU2237443382.USD","LU2471134879.HKD","LU2471134952.CNY","SRPU","IE0009355771.USD","LU0061475181.USD","BK4552","BK4588","IE00B2B36J28.USD","IE00B19Z3581.USD","IE00BJJMRZ35.SGD","IE00BSNM7G36.USD","BK4533","LU2237443465.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638552804","title":"A Look At Sarepta Therapeutics (SRPT) Valuation After Recent Share Price Weakness And ELEVIDYS Safety Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=2638552804","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638552804?lang=en_us&edition=fundamental","pubTime":"2026-05-27 03:27","pubTimestamp":1779823669,"startTime":"0","endTime":"0","summary":"Recent performance context for Sarepta Therapeutics\nSarepta Therapeutics (SRPT) has drawn investor attention after a period of pressure on the stock, with the share price closing at US$16.80 and posting declines over the past month and past 3 months.\nThose moves come against a backdrop of weaker trailing returns over the past year and multi year periods. This has prompted investors to reassess how the company’s current revenue base of US$2.18b and net income of US$65.06m line up with today’s...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-srpt/sarepta-therapeutics/news/a-look-at-sarepta-therapeutics-srpt-valuation-after-recent-s-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-srpt/sarepta-therapeutics/news/a-look-at-sarepta-therapeutics-srpt-valuation-after-recent-s-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","IE0002141913.USD","BK4585","BK4139","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","SRPU","IE0009355771.USD","SRPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636641856","title":"J.P. Morgan Remains a Hold on Sarepta Therapeutics (SRPT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2636641856","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636641856?lang=en_us&edition=fundamental","pubTime":"2026-05-19 20:16","pubTimestamp":1779192981,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Anupam Rama from J.P. Morgan maintained a Hold rating on Sarepta Therapeutics, with a price target of $19.00. The c...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/j-p-morgan-remains-a-hold-on-sarepta-therapeutics-srpt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/j-p-morgan-remains-a-hold-on-sarepta-therapeutics-srpt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1244550494.USD","LU2111349929.HKD","SRPU","LU0267386448.USD","LU2264538146.SGD","LU1064131342.USD","IE0002141913.USD","LU1548497426.USD","IE00BJJMRZ35.SGD","LU0158827781.USD","LU0882574139.USD","LU1244550577.SGD","LU0320765646.SGD","LU0106261372.USD","LU1363072403.SGD","LU1989772840.SGD","SRPT","LU0234570918.USD","IE00B2B36J28.USD","LU1732799900.SGD","IE00BFTCPJ56.SGD","BK4516","BK4504","IE0009355771.USD","LU0390134368.USD","LU1720051017.SGD","BK4588","LU1732800096.USD","LU2271345857.HKD","BK4585","LU1989772923.USD","LU0225283273.USD","LU1720051108.HKD","LU2133065610.SGD","LU0053666078.USD","LU0314104364.USD","IE00BJT1NW94.SGD","LU2357305700.SGD","LU2089283258.USD","LU0795875169.SGD","LU1244550221.USD","LU2089284900.SGD","LU0528227936.USD","LU0912757837.SGD","LU0210528500.USD","BK4127","BK4139","LU0795875086.SGD","BK4581","LU2023251221.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635103519","title":"Sarepta's Elevidys Faces 'Little' Pressure After Regenxbio Data, Wedbush Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2635103519","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635103519?lang=en_us&edition=fundamental","pubTime":"2026-05-15 23:29","pubTimestamp":1778858950,"startTime":"0","endTime":"0","summary":"Sarepta Therapeutics'  Elevidys is put under a \"little\" pressure on Regenxbio's  positive trial data in Duchenne muscular dystrophy, Wedbush Securities said in a note Friday.The note pointed to statistically significant correlation between microdystrophin expression and functional improvement in the trial of RGX-202, and should benefit all microdystrophin gene therapy programs/products.\"We see no other big impact on Elevidys,\" it said. \"We do not believe that the relatively small patient number in RGNX's study allows for a fair comparison of microdystrophin expression.\"The report also said the regulatory pathway for RGX-202 remains to be defined.Wedbush kept its outperform rating and a $35 price target.Price: 18.12, Change: -0.56, Percent Change: -3.00","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BJT1NW94.SGD","RGNX","IE00BFTCPJ56.SGD","SRPU","IE0009355771.USD","BK4585","IE0002141913.USD","SRPT","BK4139","IE00BJJMRZ35.SGD","BK4505","BK4563","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635082503","title":"Sarepta Therapeutics: Buy Rating Reiterated on Elevidys Uptake Outlook and Microdystrophin Validation; $35 Price Target Unchanged","url":"https://stock-news.laohu8.com/highlight/detail?id=2635082503","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635082503?lang=en_us&edition=fundamental","pubTime":"2026-05-15 20:36","pubTimestamp":1778848603,"startTime":"0","endTime":"0","summary":"Analyst Yun Zhong from Wedbush maintained a Buy rating on Sarepta Therapeutics and keeping the price target at $35.00. Yun Zhong has given his Buy ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/sarepta-therapeutics-buy-rating-reiterated-on-elevidys-uptake-outlook-and-microdystrophin-validation-35-price-target-unchanged-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/sarepta-therapeutics-buy-rating-reiterated-on-elevidys-uptake-outlook-and-microdystrophin-validation-35-price-target-unchanged-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SRPT"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":3,"totalSize":142,"code":"91000000","status":"200"}]}}